CMLHope.Com
A Worldwide Support Network For Chronic Myelogenous Leukemia
Posted by rob on May 30, 2007 under Uncategorized | Be the First to Comment
Long-Term Outcome of Unrelated Donor Transplantation for AML Using Myeloablative Conditioning Incorporating Pretransplant Alemtuzumab.
Familial adenomatous polyposis complicated by chronic myelogenous leukemia: response to imatinib mesylate.